Your session is about to expire
← Back to Search
High-Level Construal for Smoking Cessation
N/A
Recruiting
Led By Elliot T Berkman, Ph.D.
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 25-55
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline
Awards & highlights
Study Summary
This trial is researching whether a new treatment for smoking cessation, called high-level construal, is effective. The study will compare high-level construal to a standard text-messaging intervention to see if it results in fewer cigarettes smoked per day.
Who is the study for?
Adult smokers aged 25-55, living with low income (below 200% of the federal poverty line), who have tried and failed to quit smoking. They must be willing to use nicotine replacement therapy provided or their own throughout the study. Pregnant women, individuals with metal implants, electronic medical devices, or those weighing over 550 lbs are excluded.Check my eligibility
What is being tested?
The trial is testing whether changing how people think about their goals (high-level construal) can help them regulate emotions and quit smoking more effectively than traditional methods like reducing cravings directly. Participants' brain activity will be monitored to see if this new approach works differently from standard treatments.See study design
What are the potential side effects?
Since this trial involves psychological training rather than medication, there may not be direct physical side effects. However, participants might experience stress or discomfort related to changes in thinking patterns or while trying to quit smoking.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 25 and 55 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within two weeks of enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within two weeks of enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Aim 1: Neural similarity at baseline among the proposed psychological mechanisms
Nerve Block
Aim 2: Correlation of pattern representation of high-level construal with survey measure
+3 moreSecondary outcome measures
Aim 3: Effect size of high-level construal on smoking at endpoint
Aim 3: Time-series of the effect size of high-level construal on smoking across the training period
Trial Design
3Treatment groups
Experimental Treatment
Group I: Up-regulation of goal energizationExperimental Treatment1 Intervention
Participants will be sent messages that encourage them to consider the core values that drive their desire to quit smoking.
Group II: High-level construalExperimental Treatment1 Intervention
Participants will be sent messages asking them to imagine what their lives will look like in the future if they succeed ("What would quitting mean to you and your family's future?"; Yeager et al., 2014).
Group III: Effortful down-regulation of craving for cigarettesExperimental Treatment1 Intervention
Participants will be sent messages that encourage inhibitory control of cravings for cigarettes (e.g., using cognitive reappraisal or attentional control) and that provide strategies to do so (e.g., "When you feel an urge to smoke, think about the health consequences").
Find a Location
Who is running the clinical trial?
University of OregonLead Sponsor
80 Previous Clinical Trials
46,606 Total Patients Enrolled
Ohio State UniversityOTHER
830 Previous Clinical Trials
505,444 Total Patients Enrolled
Elliot T Berkman, Ph.D.Principal InvestigatorUniversity of Oregon
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You smoke cigarettes regularly, at least 10 cigarettes per day for at least 1 year.I have tried and failed to quit at least once.I am between 25 and 55 years old.I use e-cigarettes, but I understand it will be noted for the study.I am using or willing to use nicotine replacement therapy (NRT) to quit smoking.I am pregnant or might be pregnant.You have metal fragments, pacemakers, or other electronic medical implants in your body.My gender, race, or ethnicity does not affect my eligibility.I suffer from claustrophobia.
Research Study Groups:
This trial has the following groups:- Group 1: Effortful down-regulation of craving for cigarettes
- Group 2: High-level construal
- Group 3: Up-regulation of goal energization
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still vacancies for participation in this experiment?
"Yes, according to clinicialtrials.gov this study is actively recruiting qualified patients. This experiment was first advertised on October 11th 2021 and has been revised most recently on February 10th 2022."
Answered by AI
Is there an age minimum or maximum for enrolment into this trial?
"This research initiative seeks participants aged 25-55 years old."
Answered by AI
How many individuals are taking part in this investigation?
"Affirmative. According to clinicaltrials.gov, this medical trial is recruiting participants since its initial posting on October 11th 2021 and last modification on February 10 2022. Two sites are enrolling a total of 240 patients into the study."
Answered by AI
Is there a way I can participate in this exploration?
"This medical trial is recruiting up to 240 individuals, aged between 25 and 55, with a malignancy. Participants must meet certain socioeconomic requirements: low-SES, three failed attempts to quit smoking, INR of less than 1.0 (household income adjusted for household size below the federal poverty line), persistent smokers (at least 10 cigarettes/day for at least 2 years)."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger